Generate QR code
Open Access
Subscription Access
Hypertrophic apical cardiomyopathy (Yamaguchi syndrome): decision-making tactics
https://doi.org/10.30629/0023-2149-2025-103-10-11-827-835
Abstract
The article describes apical hypertrophic cardiopathy, its etiology and pathogenesis. A clinical case of a patient with apical hypertrophic cardiomyopathy is presented. The features of the course of the disease, modern approaches to assessing the prognosis are described. The issues of differential diagnosis are considered.
About the Authors
N. I. Gulyaev
National Medical Research Center of High Medical Technologies — A.A. Vishnevsky Central Military Clinical Hospital of the Ministry of Defense of Russia; Branch of the Military Medical Academy named after S.M. Kirov of the Russian Ministry of Defense in Moscow; Patrice Lumumba Peoples’ Friendship University of Russia, Ministry of Education and Science of the Russian Federation
Russian Federation
Russian Federation
Nikolai I. Gulyaev — Doctor of Medical Sciences, Professor, Head of the Cardiology Center of the Vishnevsky National Research Medical Center of the Russian Ministry of Defense.
Krasnogorsk; Moscow
Yu. V. Ovchinnikov
Branch of the Military Medical Academy named after S.M. Kirov of the Russian Ministry of Defense in Moscow
Russian Federation
Russian Federation
Yuri V. Ovchinnikov — Doctor of Medical Sciences, Professor, Branch of the Federal State Budgetary Educational Institution of Higher Education named after S.M. Kirov of the Ministry of Defense of the Russian Federation in Moscow.
Moscow
N. A. Varavin
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russia
Russian Federation
Russian Federation
Nikita A. Varavin — Candidate of Medical Sciences, senior resident of the Cardiology Department of the 1st Department (Advanced Medical Therapy) named after Academician N.S. Molchanov of the Federal State Budgetary Educational Institution of Higher Medical Education named after S.M. Kirov of the Ministry of Defense of the Russian Federation.
St. Petersburg
I. A. Puzhalov
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russia
Russian Federation
Russian Federation
Ilya A. Puzhalov — residency student, member of the Military Scientific Society of Cadets and Trainees at the 1st Department (Advanced Medical Training Therapy) named after Academician N.S. Molchanov of the Federal State Budgetary Educational Institution of Higher Medical Education named after S.M. Kirov of the Ministry of Defense of the Russian Federation.
St. Petersburg
A. A. Santakov
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russia
Russian Federation
Russian Federation
Alexandr A. Santakov — residency student, member of the Military Scientific Society of Cadets and Trainees at the 1st Department (Advanced Medical Training Therapy) named after Academician N.S. Molchanov of the Federal State Budgetary Educational Institution of Higher Medical Education named after S.M. Kirov of the Ministry of Defense of the Russian Federation.
St. Petersburg
I. A. Menkov
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russia
Russian Federation
Russian Federation
Igor A. Menkov — Candidate of Medical Sciences, Head of the Department — Radiologist of the X-ray Department of Radiation Diagnostics (inpatient patients) of the Clinic of Radiology and Radiology of the Federal State Budgetary Educational Institution of Higher Medical Education named after S.M. Kirov of the Ministry of Defense of the Russian Federation.
St. Petersburg
References
1. Klarich K.W., Christine H Attenhofer Jost, Josepha Binder, et al. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am. J. Cardiol. 2013; 111 (12): 1784—1791. Doi: 10.1016/j.amjcard.2013.02.040
2. Neubauer S., Kolm P., Ho C.Y. et al. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. J. Am. Coll. Cardiol. 2019;74:2333-45. DOI: 10.1016/j.jacc.2019.08.1057
3. Jan M.F., Todaro M.C., Oreto L., Tajik A.J. Apical hypertrophic cardiomyopathy: Present status. Int. J. Cardiol. 2016;222:745-59. DOI: 10.1016/j.ijcard.2016.07.154
4. Towe E.C., Bos J.M., Ommen S.R. et. al. Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy. Congenit. Heart Dis. 2015;10:E139-45. DOI: 10.1111/chd.12242
5. Ader F., Jedraszak G., Janin A., et al. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy. Clin. Genet. 2024;105:676-82. DOI: 10.1111/cge.14505
6. Huang Z., Lin K., Huang J., Chen Y. et al. Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and metaanalysis. Int. J. Cardiol. 2024; 409:132213. DOI: 10.1016/j.ijcard.2024.132213
7. Curran L., de Marvao A., Inglese P. et al. Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy. Circ. Genom Precis. Med. 2023;16:e004200. DOI: 10.1161/CIRCGEN.123.004200
8. Hughes R.K., Knott K.D., Malcolmson J. et al. Apical Hypertrophic Cardiomyopathy: The Variant Less Known. J. Am. Heart. Assoc. 2020;9:e015294. DOI: 10.1161/JAHA.119.015294
9. Pelliccia F., Pasceri V., Limongelli G. et al. Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis. Int. J. Cardiol. 2017;243:379-84. DOI: 10.1016/j.ijcard.2017.06.071
10. Ma H., Zhou Y., He Y. et al. Prognosis for patients with apical hypertrophic cardiomyopathy: A multicenter cohort study based on propensity score matching. Kardiol. Pol. 2023;81:1247-56. DOI: 10.33963/v.kp.98355
11. Kim E.K., Lee S., Hwang J.W. et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur. Heart J. Cardiovasc. Imaging. 2016;17:678-86. DOI: 10.1093/ehjci/jev192
12. Rouskas P., Zegkos T., Ntelios D. et al. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy. Hellenic Journal of Cardiology. 2023;73:8-15. DOI: 10.1016/j.hjc.2023.02.004
13. Maron M.S., Rowin E.J., Wessler B.S. et al. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019;4:644. DOI: 10.1001/jamacardio.2019.1391
14. Flores R.F., Mane F., Antunes N., Pereira V.H. Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report. Eur. Heart J. Case Rep. 2020;4:1-4. DOI: 10.1093/ehjcr/ytaa316
15. Rathore A., Fortier J.C., Chen K. et. al. High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable CardioverterDefibrillator: A Case Report of an Overlooked Etiology. Cureus. 2023;8;15(7):e41564. DOI: 10.7759/cureus.41564
16. Kubo T., Kitaoka H., Okawa M. et al. Clinical Profiles of Hypertrophic Cardiomyopathy With Apical Phenotype Comparison of Pure-Apical Form and Distal-Dominant Form. Circulation Journal. 2009;73:2330-6. DOI: 10.1253/circj.CJ-09-0438
17. Wang C., Zhou W., Geske J.B. et al. Clinical Implications of Left Ventricular Apex Mechanics in Patients With Apical Hypertrophic Cardiomyopathy. Journal of the American Society of Echocardiography. 2024. DOI: 10.1016/j.echo.2024.08.016
18. Mihos C.G., Horvath S.A., Fernandez R., Escolar E. Left ventricular strain and myocardial work in apical hypertrophic cardiomyopathy. J. Thorac. Dis. 2023;15:3197-207. DOI: 10.21037/jtd-23-202
19. Rowin E.J., Maron M.S., Adler A. et al. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study. Heart Rhythm. 2022;19:782-9. DOI: 10.1016/j.hrthm.2021.12.017
20. Parcharidou D., Zegkos T., Ntelios D. et al. The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort. Journal of Cardiovascular Medicine. 2020;21:428-34. DOI: 10.2459/JCM.0000000000000945
21. Goncharova D.Yu., Bikbaeva G.R., Tukhbatova A.A. and others. Apical hypertrophic cardiomyopathy as a mask of acute coronary syndrome. Clinical observations. Russian Journal of Cardiology. 2022;27(4S):5262. (In Russian). DOI: 10.15829/1560-4071-2022-5262. EDN GOFPPS
22. Chanakhchyan F.N., Gulyaev N.I., Slivinsky D.V. and others. Multimodal imaging in the diagnosis of apical hypertrophic cardiomyopathy: a clinical case. Radiation diagnostics and therapy. 2023;14(3):93-98. (In Russian). DOI: 10.22328/2079-5343-2023-14-3-93-98
23. Tang Y., Ma X., Wang J. et al. Incremental prognostic value of left atrial strain in apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study. Eur. Radiol. 2024;55(1):83-91. DOI: 10.1007/s00330-024-11058-y
24. Ye T.T.S., Siah Q.Z., Tan B.Y.Q. et al. Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis. J. Thromb. Thrombolysis. 2022;55:83-91. DOI: 10.1007/s11239-022-02713-6
25. Shirotani S., Minami Y., Saito C. et al. B-type natriuretic peptide and outcome in patients with apical hypertrophic cardiomyopathy. J. Cardiol. 2020;76:357-63. DOI: 10.1016/j.jjcc.2020.03.015
26. Mihos C.G., Escolar E., Fernandez R. Right ventricular hypertrophy in apical hypertrophic cardiomyopathy. Echocardiography. 2023;40:515-23. DOI: 10.1111/echo.15588
27. Ignatenko G.A., Taradin G.G., Kugler T.E., Kulikova S.O. Features of left ventricular outflow tract obstruction in patients with various phenotypes of hypertrophic cardiomyopathy. Cardiology and cardiovascular surgery. 2024;17(1):7-13. (In Russian). DOI: 10.17116/kardio2024170117
28. Konstantinov I.E., Fricke T.A. Commentary: A paradigm change in surgical management of the apical hypertrophic cardiomyopathy to avoid heart transplantation. J. Thorac. Cardiovasc. Surg. 2024;26:S0022-5223(24)00658-5. DOI: 10.1016/j.jtcvs.2024.07.042
29. Afanasyev A.V., Bogachev-Prokofiev A.V., Kirilova V.S. and others. Transapical myoectomy as an alternative to heart transplantation in a patient with apical hypertrophic cardiomyopathy. Clinical and experimental surgery. The journal named after academician B.V. Petrovsky. 2024;12(1):127-134. (In Russian). DOI: 10.33029/23081198-2024-12-1-127-134
30. Lysenko A.V., Salagaev G.I., Lednev P.V. and others. Combined transapical and transaortic myectomy in a patient with hypertrophic cardiomyopathy. Cardiology and cardiovascular surgery. 2021;14(3):220-223. (In Russian). DOI: 10.17116/kardio202114031220
31. Fang J., Liu Y., Zhu Y. et al. First-in-human transapical beatingheart septal myectomy in patients with hypertrophic obstructive cardiomyopathy. J. Am. Coll. Cardiol. 2023;82:575-86. DOI: 10.1016/j.jacc.2023.05.052
Review
For citations:
Gulyaev N.I., Ovchinnikov Yu.V., Varavin N.A., Puzhalov I.A., Santakov A.A., Menkov I.A. Hypertrophic apical cardiomyopathy (Yamaguchi syndrome): decision-making tactics. Clinical Medicine (Russian Journal). 2025;103(10-11):827-835. (In Russ.) https://doi.org/10.30629/0023-2149-2025-103-10-11-827-835
Views:
338
JATS XML
Email this article 